Stocks · Healthcare · Medical - Healthcare Plans
Elevance Health Inc. ELV
$386.43 +1.25% Close, Oct 2, 2026 · NYSE · Market cap $83.80B
Inexpensive vs sectorLow risk
Next earnings report: Oct 21, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- The stock is in an uptrend: above its 200-day average for 115 trading days, with the 50-day average above the 200-day.
- Earnings beat analyst estimates in each of the last 4 quarters (average surprise over the last four: +16.5%).
- Revenue over the last four quarters was $201.11B, up 6.3% from a year earlier, slowing from 9.4% a quarter earlier.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth36Weak
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 43%
- EPS growth (TTM, YoY)Bottom 41%
- FCF growth (TTM, YoY)Top 45%
- Revenue growth, 3-year CAGRBottom 45%
- Revenue growth accelerationBottom 31%
Quality57Neutral
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 21%
- Gross marginBottom 25%
- Operating marginTop 37%
- Cash conversion (OCF / net income)Bottom 46%
- Accruals (lower is better)Bottom 24%
- Net debt / EBITDA (lower is better)Bottom 34%
- Interest coverTop 23%
Value96Exceptional
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 8%
- Free-cash-flow yieldTop 11%
- EBITDA / enterprise valueTop 14%
- Sales / enterprise valueTop 4%
- P/E vs own 5-year history (lower is better)Top 40%
Momentum66Positive
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 49%
- 6-month returnTop 33%
- 1-year return vs S&P 500Top 46%
- Distance from 52-week highTop 18%
- Trend checklist (0–4)Top 39%
Revisions60Neutral
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 28%
- Consecutive EPS beatsTop 19%
- Share of analysts rating BuyBottom 40%
- Upside to consensus price targetBottom 23%
Stability82Strong
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 12%
- Maximum drawdown, 3 yearsTop 25%
- Beta vs S&P 500 (lower is better)Top 13%
- Net debt / EBITDA (lower is better)Bottom 34%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 9.4% | 6.3% | ↓ |
| EPS growth (YoY) | -8.3% | -4.3% | ↑ |
| Gross margin | 26.8% | 39.0% | ↑ |
| Operating margin | 4.5% | 3.5% | ↓ |
| FCF margin | 2.8% | 3.1% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 6.3% | 9.4% | ↓ | Bottom 43% |
| EPS growth (TTM, YoY) | -4.3% | -8.3% | ↑ | Bottom 41% |
| Gross margin | 39.0% | 26.8% | ↑ | Bottom 25% |
| Operating margin | 3.5% | 4.5% | ↓ | Top 37% |
| Net margin | 2.5% | 2.8% | ↓ | — |
| Free-cash-flow margin | 3.1% | 2.8% | ↑ | — |
| Return on invested capital | 6.3% | — | Top 21% | |
| Revenue growth, 3-year CAGR | 8.3% | — | Bottom 45% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.50×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -2.0%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.1%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +40.7 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 2.60×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 6.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 1.80%
- Net buyback yield (TTM)
- 3.16%
- Shareholder yield
- 4.96%
- Share count change, 1 year
- -3.5%
- Share count change, 3-year CAGR
- -2.9%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Jul 15, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 4
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +16.5%
- Average 2-day reaction, last 8
- -2.7%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $444.06
- Target vs current price
- +14.9%
- Analysts with a rating
- 38
- Share rating Buy or Strong Buy
- 71%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Jul 15, 2026 | +20.0% | -8.5% | -7.8% | -8.5% | — |
| Apr 22, 2026 | +16.3% | +0.0% | +10.6% | +22.6% | +13.7% |
| Jan 28, 2026 | +7.4% | +5.9% | +4.9% | +2.4% | +7.2% |
| Oct 21, 2025 | +22.3% | -1.2% | -3.3% | -6.5% | +7.9% |
| Jul 17, 2025 | -0.8% | -12.2% | -13.9% | -14.5% | +3.9% |
| Apr 22, 2025 | +4.9% | +2.3% | +1.8% | -0.7% | -25.6% |
| Jan 23, 2025 | +1.1% | +2.7% | +2.4% | -0.1% | +8.7% |
| Oct 17, 2024 | -13.4% | -10.6% | -16.4% | -17.3% | -20.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Jul 15, 2026 | $7.45 | $6.21 | +20.0% | $49.83B |
| Apr 22, 2026 | $12.58 | $10.82 | +16.3% | $49.49B |
| Jan 28, 2026 | $3.33 | $3.10 | +7.4% | $49.31B |
| Oct 21, 2025 | $6.03 | $4.93 | +22.3% | $50.09B |
| Jul 17, 2025 | $8.84 | $8.91 | -0.8% | $49.42B |
| Apr 22, 2025 | $11.97 | $11.41 | +4.9% | $48.77B |
| Jan 23, 2025 | $3.84 | $3.80 | +1.1% | $45.44B |
| Oct 17, 2024 | $8.37 | $9.66 | -13.4% | $45.15B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 17.2× | 18.3× | 33th | Top 8% |
| P/E (forward) | 14.2× | — | — | — |
| EV / EBITDA | 13.1× | — | — | Top 14% |
| EV / Sales | 0.52× | — | — | Top 4% |
| Free-cash-flow yield | 7.50% | — | — | Top 11% |
| Earnings yield | 5.82% | — | — | Top 8% |
P/E over the past five years
Range 12.9× – 22.5× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +16.2%
- Earnings per share growth (TTM)
- -4.3%
- Change in P/E multiple
- +34.8%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 115
- 50-day average slope (20 days)
- +0.3%
- 200-day average slope (20 days)
- +1.9%
- Distance from 50-day average
- -2.7%
- Distance from 200-day average
- +5.6%
- RSI (14)
- 39.1
- Relative volume
- 0.70×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 32.0%
- Volatility vs own 5-year history
- 76th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.44
- Correlation with S&P 500
- 0.20
- Current drawdown from 1-year high
- -9.5%
- Maximum drawdown, 3 years
- -51.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 3, 2024 | Aug 1, 2025 | -51.1% | 228 days | Not yet recovered |
| Oct 31, 2022 | Jul 12, 2023 | -24.3% | 173 days | 215 days (May 17, 2024) |
| Apr 20, 2022 | Jun 17, 2022 | -16.1% | 41 days | 90 days (Oct 26, 2022) |
| Jan 11, 2021 | Feb 8, 2021 | -15.1% | 19 days | 19 days (Mar 8, 2021) |
| Oct 23, 2020 | Oct 30, 2020 | -12.2% | 5 days | 3 days (Nov 4, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $83.80B
- P/E (TTM)
- 17.2
- EPS, diluted (TTM)
- $22.50
- Revenue (TTM)
- $201.11B
- Dividend yield
- 1.78%
- 52-week range
- $274.84 – $436.24
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $138.64B | $156.59B | $171.34B | $176.81B | $199.13B |
| Gross profit | $35.99B | $39.95B | $47.01B | $49.24B | $50.90B |
| Operating income | $8.95B | $8.45B | $8.74B | $8.89B | $8.11B |
| Net income | $6.10B | $5.89B | $5.99B | $5.98B | $5.66B |
| EPS (diluted) | $24.73 | $24.28 | $25.22 | $25.68 | $25.12 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $45.15B | $45.44B | $48.89B | $49.78B | $50.71B | $49.75B | $50.18B | $50.47B |
| Net income | $1.02B | $418.0M | $2.18B | $1.74B | $1.19B | $547.0M | $1.76B | $1.46B |
| EPS (diluted) | $4.36 | $1.81 | $9.61 | $7.72 | $5.32 | $2.47 | $8.00 | $6.71 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $8.36B | $8.40B | $8.06B | $5.81B | $4.29B |
| Capital expenditure | -$1.09B | -$1.15B | -$1.30B | -$1.26B | -$1.12B |
| Free cash flow | $7.28B | $7.25B | $6.76B | $4.55B | $3.17B |
| Dividends paid | -$1.10B | -$1.23B | -$1.40B | -$1.51B | -$1.53B |
| Net share buybacks | -$1.90B | -$2.32B | -$2.68B | -$2.90B | -$2.60B |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $37.51B
- Total assets
- $126.44B
- Total liabilities
- $81.42B
- Total debt
- $31.04B
- Net debt
- $20.81B
- Shareholders’ equity
- $44.88B
As of Jun 30, 2026 (filed Jul 15, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Sep 10, 2026 | $1.72 | Sep 25, 2026 |
| Jun 10, 2026 | $1.72 | Jun 25, 2026 |
| Mar 10, 2026 | $1.72 | Mar 25, 2026 |
| Dec 5, 2025 | $1.71 | Dec 19, 2025 |
| Sep 10, 2025 | $1.71 | Sep 25, 2025 |
| Jun 10, 2025 | $1.71 | Jun 25, 2025 |
| Mar 10, 2025 | $1.71 | Mar 25, 2025 |
| Dec 5, 2024 | $1.63 | Dec 20, 2024 |
Short interest
- Shares sold short
- 5,335,623
- Days to cover
- 4.21
- Change vs previous report
- -2.7%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jun 1, 2005
- 2-for-1